FFCP PHASE2:Hg19::chr2:9563769..9563832,+
From FANTOM5_SSTAR
Jump to: navigation, search
| Short description: | p1@CPSF3 |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_1_at_CPSF3_5end |
| Coexpression cluster: | C896_retinoblastoma_iPS_acute_lymphoma_chronic_Burkitt_testicular |
| Association with transcript: | 0bp_to_ENST00000427001, ENST00000475482, ENST00000540142_5end |
| EntrezGene: | CPSF3 |
| HGNC: | 2326 |
| UniProt: | E7ER23C9JZH6F5GXZ2 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p1@CPSF3 |
|---|
0
20
40
60
80
100
120
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| cancer | 1.03e-42 | 235 |
| disease of cellular proliferation | 1.59e-41 | 239 |
| organ system cancer | 1.87e-23 | 137 |
| hematologic cancer | 9.92e-23 | 51 |
| immune system cancer | 9.92e-23 | 51 |
| leukemia | 1.69e-18 | 39 |
| cell type cancer | 7.64e-18 | 143 |
| myeloid leukemia | 1.63e-14 | 31 |
| carcinoma | 9.42e-13 | 106 |
| germ cell and embryonal cancer | 8.76e-07 | 22 |
Showing 1 to 10 of 11 entries
